GPT and metabolic dysfunction-associated steatotic liver disease: Other biochemical parameters associated with NASH and NAFLD also improved on therapy with this dose, as noted by significant decreases in serum alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) levels.